These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10341161)

  • 1. Disposition of D-[U-14C]tagatose in the rat.
    Saunders JP; Zehner LR; Levin GV
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S46-56. PubMed ID: 10341161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of 14C-erythritol in germfree and conventional rats.
    Van Ommen B; de Bie B; Bär A
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 2):S198-205. PubMed ID: 8933634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
    De Bie AT; Van Ommen B; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-bowel absorption of D-tagatose and related effects on carbohydrate digestibility: an ileostomy study.
    Normén L; Laerke HN; Jensen BB; Langkilde AM; Andersson H
    Am J Clin Nutr; 2001 Jan; 73(1):105-10. PubMed ID: 11124758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of D-tagatose on liver weight and glycogen content of rats.
    Bär A; Lina BA; de Groot DM; de Bie B; Appel MJ
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S11-28. PubMed ID: 10341157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fermentation pattern of D-tagatose is affected by adaptation of the microbiota from the gastrointestinal tract of pigs.
    Laerke HN; Jensen BB; Højsgaard S
    J Nutr; 2000 Jul; 130(7):1772-9. PubMed ID: 10867049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
    Van Ommen B; De Bie AT; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 90-Day oral toxicity study of D-tagatose in rats.
    Kruger CL; Whittaker MH; Frankos VH; Trimmer GW
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S1-10. PubMed ID: 10341156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental toxicity study of D-tagatose in rats.
    Kruger CL; Whittaker MH; Frankos VH; Schroeder RE
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S29-35. PubMed ID: 10341158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans.
    Saunders JP; Donner TW; Sadler JH; Levin GV; Makris NG
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 2):S57-65. PubMed ID: 10341162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration.
    Buemann B; Toubro S; Holst JJ; Rehfeld JF; Bibby BM; Astrup A
    Metabolism; 2000 Aug; 49(8):969-76. PubMed ID: 10954012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-tagatose is a bulk sweetener with zero energy determined in rats.
    Livesey G; Brown JC
    J Nutr; 1996 Jun; 126(6):1601-9. PubMed ID: 8648434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 2-mercaptobenzothiazole and 2-mercaptobenzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL; Barnett JW
    J Toxicol Environ Health; 1989; 27(1):65-84. PubMed ID: 2724369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependency of fermentation and the extent of renal excretion of palatinit (isomalt) in rats with respect to its energy value.
    Herfarth H; Klingebiel L; Juhr NC; Grossklaus R
    Z Ernahrungswiss; 1994 Sep; 33(3):185-94. PubMed ID: 7810177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of 9-aminoacridine in rats dosed orally or intravenously and in monkeys dosed topically.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL
    J Toxicol Environ Health; 1985; 15(6):789-99. PubMed ID: 4057283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
    Emary WB; Toren PC; Mathews B; Huh K
    Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL
    J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tagatose, the new GRAS sweetener and health product.
    Levin GV
    J Med Food; 2002; 5(1):23-36. PubMed ID: 12511110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.